Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 (COVID-19) RBD Neutralizing | monoclonal | Recombinant | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike S2 | monoclonal | Mouse | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS CoV2 Spike protein-RBD | polyclonal | Goat | SARS-CoV2 | antigen affinity purified | 100µg in 200µl | n/a |
EVEREST BIOTECH LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | F(ab)2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | F(ab)2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Ferret | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Rabbit | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Ferret | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Cat | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Cat | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Ferret | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 (COVID-19) E protein | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |